SunLink Health Systems

SunLink Health Systems, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a bed community hospital and bed nursing home Information Technology (IT) service company, and healthcare facilities, which are leased to third parties. The Pharmacy segment manages a pharmacy business with service lines. The company was founded in June 1959 and is headquartered in Atlanta, GA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SunLink Health Systems, Inc. engages in the provision of healthcare products and services. It operates through the Healthcare Services and Pharmacy segment. The Healthcare Services segment owns and operates a bed community hospital, clinics, bed nursing home, and Information Technology (IT) service company which are leased to third parties. The Pharmacy segment is involved in the pharmacy business in Louisiana with four operational areas. The company was founded in June 1959 and is headquartered in Atlanta, GA.

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing operations of $2,277,000 (or $0.32 per fully diluted share) for the second fiscal quarter ended December 31, 2022. Net loss for the quarter ended December 31, 2023 was $3,075,000 (or a loss of $0.44 per fully diluted share) c.

SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its indirect subsidiary, Southern Health Corporation of Houston, Inc. (“Southern”), has reached a revised agreement for the sale of Trace Regional Hospital and three (3) patient clinics in Chickasaw County, MS, (“Trace”) to Progressive Health of Houston, LLC (“Progressive”). Southern sold certain personal and intangible property to Progressive for $500,000 pursuant to an asset purchase agreement, e.

Sunlink Health Systems' Subsidiary Reaches Revised Agreements for the Sale of Trace Regional Medical Center and Clinics

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) today announced that SunLink and Progressive Health Group, LLC (“Progressive”) have amended their previously-announced agreement for the sale by SunLink's subsidiary, Crown Healthcare Investments, LLC, of Trace Regional Medical Center in Houston, Mississippi, to Progressive to, among other things, extend the closing date until January 31, 2024, on substantially the same price and terms previously announced.

SunLink Health Systems, Inc. and Progressive Health Group, LLC, Agree to Extend the Closing Date of Their Previously-Announced Sale of Trace Regional Medical Center

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2023 compared to a loss from continuing operations of $605,000 (or a loss of $0.09 per fully diluted share) for the first fiscal quarter ended September 30, 2022. On November 10, 2023, the Company's subsidiary, Crown Healthcare Investments, LLC, signed an agreement w.

SunLink Health Systems, Inc. Announces Fiscal 2024 First Quarter Results

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed an agreement with Progressive Health Group, LLC (“Buyer”) for the sale of the subsidiary that owns and operates Trace Regional Medical Center, which includes a hospital, skilled nursing facility and three (3) patient clinics in Chickasaw County, MS, for approximately $8,000,000.

SunLink Health Systems Reaches Agreement for Sale of Trace Regional Medical Center

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,436,000 (or a loss of $0.20 per fully diluted share) for its fourth fiscal quarter ended June 30, 2023 compared to a loss from continuing operations of $2,317,000 (or a loss of $0.33 per fully diluted share) for the fourth fiscal quarter ended June 30, 2022. Net loss for the quarter ended June 30, 2023 was $1,426,000 (or a loss of $0.20 per fully diluted share) com.

SunLink Health Systems, Inc. Announces Fiscal 2023 Fourth Quarter and Annual Results

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced that its Board of Directors (a) declared a dividend of one one-thousandth (1/1,000th) of a share (each a “Series C Fractional Interest”) of the Company's newly-designated Series C Redeemable Preferred Shares, no par value per share (the “Series C Preferred Shares”), for each outstanding common share of the Company (the “Common Shares”), payable on August 16, 2023 to shareholders of record as of 5:00 p.m.

SunLink Health Systems, Inc. Announces Dividend of Fractional Interests in Series C Redeemable Preferred Shares to Holders of Its Common Shares

ATLANTA--(BUSINESS WIRE)--On July 20, 2023, the board of directors (the “Board”) of SunLink Health Systems, Inc. (NYSE American: SSY) (“SSY,” the “Company,” “we,” “us” or “our”) filled a vacant seat on the Board of Directors by electing Mark J. Stockslager as a director of the Company. Mr. Stockslager, 63, has been SunLink's Chief Financial Officer since July 1, 2007. He was interim Chief Financial Officer from November 6, 2006 until June 30, 2007. He has been the Principal Accounting Officer s.

SunLink Health Systems, Inc. Announces the Election of Mark J. Stockslager as Director to Board of Directors

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $727,000 (or a loss of $0.10 per fully diluted share) for its third fiscal quarter ended March 31, 2023 compared to a loss from continuing operations of $934,000 (or a loss of $0.13 per fully diluted share) for the third fiscal quarter ended March 31, 2022. Net loss for the quarter ended March 31, 2023 was $762,000 (or a loss of $0.11 per fully diluted share) compared.

SunLink Health Systems, Inc. Announces Fiscal 2023 Third Quarter Results

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $2,052,000 ($0.29 per fully diluted share) for its second fiscal quarter ended December 31, 2022 compared to a loss from continuing operations of $477,000 (or a loss of $0.07 per fully diluted share) for the second fiscal quarter ended December 31, 2021. Net earnings for the quarter ended December 31, 2022 were $1,951,000 ($0.

SunLink Health Systems, Inc. Announces Fiscal 2023 Second Quarter Results

ATLANTA--( BUSINESS WIRE )--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,544,000 (or a loss of $0.22 per fully diluted share) for its first fiscal quarter ended September 30, 2022 compared to earnings from continuing operations of $2,006,000 (or $0.28 per fully diluted share) for the fourth fiscal quarter ended September 30, 2021. Net loss for the quarter ended September 30, 2022 was a loss of $1,558,000 (or a loss of $0.22 per fully diluted share) compared to net earnings of $1,939,000 (or $0.27 per fully diluted share) for the quarter ended June 30, 2021.

SunLink Health Systems, Inc. Announces Fiscal 2023 First Quarter and COVID-19 Update

The best nano-cap stocks to buy can represent straight-up gambles. Therefore, market participants unaccustomed to extreme volatility should get the heck out of Dodge.

The 7 Best Nano-Cap Stocks to Buy Now

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $2,317,000 (or a loss of $0.33 per fully diluted share) for its fourth fiscal quarter ended June 30, 2022 compared to earnings from continuing operations of $4,555,000 (or $0.64 per fully diluted share) for the fourth fiscal quarter ended June 30, 2021. Net loss for the quarter ended June 30, 2022 was $2,365,000 (or a loss of $0.34 per fully diluted share) compared to

SunLink Health Systems, Inc. Announces Fiscal 2022 Fourth Quarter and Annual Results and COVID-19 Update

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $934,000 (or a loss of $0.13 per fully diluted share) for its third fiscal quarter ended March 31, 2022 compared to a loss from continuing operations of $473,000 (or a loss of $0.07 per fully diluted share) for the third fiscal quarter ended March 31, 2021. Provider Relief Funds (“PRF”) of $106,000 (pre-tax) were reported as income in the quarter ended March 31, 2022

SunLink Health Systems, Inc. Announces Fiscal 2022 Third Quarter Results and COVID-19 Update

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $477,000 (or a loss of $0.07 per fully diluted share) for its second fiscal quarter ended December 3, 2021 compared to earnings from continuing operations of $3,146,000 ($0.46 per fully diluted share) for the second fiscal quarter ended December 31, 2020. Provider Relief Funds (“PRF”) of $614,000 (pre-tax) were reported as income in the quarter ended December 31, 2021

SunLink Health Systems, Inc. Announces Fiscal 2022 Second Quarter Results and COVID-19 Update

Advanced Micro Devices

Big 5 Sporting Goods

Credit Acceptance

Crescent Point Energy

Danaos

DuPont de Nemours

DAVIDsTEA

VAALCO Energy

Fulgent Genetics

Good Times Restaurants

LM Funding America

Oxbridge Re Holdings Limited

Resolute Forest Products

B. Riley Financial

Salem Media Group

SandRidge Energy

Signet Jewelers

Encore Wire

Obsidian Energy Ltd

A basic value rule of thumb for screening stocks. Screening for stocks with high fundamental scores.

Fundamental Rule Of Thumb Strategy Screen Still Valid In Today's Market

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $2,006,000 ($0.28 per fully diluted share) for its first fiscal quarter ended September 30, 2021 compared to a loss from continuing operations of $291,000 (or a loss of $0.04 per fully diluted share) for the first fiscal quarter ended September 30, 2020. Net income for the quarter ended September 30, 2021 was $1,939,000 ($0.27 per fully diluted share) compared to a

SunLink Health Systems, Inc. Announces Fiscal 2022 First Quarter Results and COVID-19 Update

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced earnings from continuing operations of $4,555,000 ($0.64 per fully diluted share) for its fourth fiscal quarter ended June 30, 2021 compared to a loss from continuing operations of $600,000 (or a loss of $0.09 per fully diluted share) for the quarter ended June 30, 2020. Net income for the quarter ended June 30, 2021 was $4,687,000 ($0.66 per fully diluted share) compared to a net loss of $679,000 (or a

SunLink Health Systems, Inc. Announces Fiscal 2021 Fourth Quarter and Annual Results and COVID-19 Update

Ault Global Holdings

Enel Chile

iBio

9F Inc - ADR

Nxt-ID

These 7 penny stocks that you may not have heard of are selling below $3 per share and are worth significantly more than their present price. The post 7 Penny Stocks to Buy if You're Looking for Hidden Gems appeared first on InvestorPlace.

7 Penny Stocks to Buy if You're Looking for Hidden Gems

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $473,000 (a loss of $0.07 per fully diluted share) for its third fiscal quarter ended March 31, 2021 compared to a loss from continuing operations of $46,000 (a loss of $0.01 per fully diluted share) for the quarter ended March 31, 2020. Net loss for the quarter ended March 31, 2021 was $531,000 (a loss of $0.08 per fully diluted share) compared to a net loss of $158,

SunLink Health Systems, Inc. Announces Fiscal 2021 Third Quarter Results and COVID-19 Update

The stock price of SunLink Health Systems, Inc. (NYSEAMERICAN: SSY) increased 6.22% from $3.70 to $3.93 pre-market. This is why it happened.

SSY Stock: 6.22% Increase (From $3.70 To $3.93) Pre-Market Explanation

The stock price of SunLink Health Systems, Inc. (NYSEAMERICAN: SSY) increased from $2.85 to a day high of $5.46. This is why it happened.

SSY Stock: From $2.85 To $5.46 (91.58% Increase) Intraday Explanation

Digital Ally Inc

Nokia

Top penny stocks to buy in May? Take a look at these 4 The post Top Penny Stocks to Buy?

Top Penny Stocks to Buy? Check These 4 Out For Your May Watchlist

Beyond Meat

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

What's Happening With BYND Stock And SSY Stock On Tuesday?

Shares of SSY stock are soaring on Tuesday after a subsidiary of SunLink Health announced a major investment in its business operations. The post SSY Stock: 6 Things to Know About SunLink Health Today as Shares Blast Higher appeared first on InvestorPlace.

News for SunLink Health Systems Stock (SSY)